Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules. | Sci Rep | 2023 | 37838783 | PubTator, text mining | PubMed |
| A Network of 17 Microtubule-Related Genes Highlights Functional Deregulations in Breast Cancer. | Cancers (Basel) | 2023 | 37835564 | PubTator, text mining | PubMed |
| Advancing Understanding of Non-Small Cell Lung Cancer with Multiplexed Antibody-Based Spatial Imaging Technologies. | Cancers (Basel) | 2023 | 37835491 | PubTator, text mining | PubMed |
| Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer. | J Ovarian Res | 2023 | 37833790 | PubTator, text mining | PubMed |
| The C-terminus of stathmin-like proteins governs the stability of their complexes with tubulin. | Biochem Biophys Res Commun | 2023 | 37826947 | PubTator, text mining | PubMed |
| From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma. | Front Oncol | 2023 | 37817774 | PubTator, text mining | PubMed |
| The Update of HIV-1 Prevalence and Incidence and Spatio-Temporal Analyses of HIV Recent Infection Among Four Sub-Groups in Sichuan, China During Surveillance Period Between 2016 and 2022. | Infect Drug Resist | 2023 | 37814665 | PubTator, text mining | PubMed |
| Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. | Acta Neuropathol Commun | 2023 | 37814347 | PubTator, text mining | PubMed |
| Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. | BMC Cancer | 2023 | 37803297 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands. | Front Immunol | 2023 | 37795090 | PubTator, text mining | PubMed |
| Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor. | bioRxiv | 2023 | 37790460 | PubTator, text mining | PubMed |
| A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma. | Adv Sci (Weinh) | 2023 | 37789644 | PubTator, text mining | PubMed |
| Cryopreservation of bioflavonoid-rich plant sources and bioflavonoid-microcapsules: emerging technologies for preserving bioactivity and enhancing nutraceutical applications. | Front Nutr | 2023 | 37781117 | PubTator, text mining | PubMed |
| Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1. | Cancer Biol Ther | 2023 | 37773733 | PubTator, text mining | PubMed |
| Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. | Front Immunol | 2023 | 37771586 | PubTator, text mining | PubMed |
| High Genetic Diversity of HIV-1 and Active Transmission Clusters among Male-to-Male Sexual Contacts (MMSCs) in Zhuhai, China. | Viruses | 2023 | 37766353 | PubTator, text mining | PubMed |
| The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach. | Int J Mol Sci | 2023 | 37762371 | PubTator, text mining | PubMed |
| High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. | Cancers (Basel) | 2023 | 37760452 | PubTator, text mining | PubMed |
| Identifying Network Biomarkers in Early Diagnosis of Hepatocellular Carcinoma via miRNA-Gene Interaction Network Analysis. | Curr Issues Mol Biol | 2023 | 37754250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=16